Suchergebnisse - "Falco, Agustín"

PubPharm (6)

1

Latin American Consensus on the Treatment of Head and Neck Cancer

enthalten in: JCO global oncology | 2024

von Matos, L. | Kowalski, L. | Chaves, A. | +42

2

First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer : A multicenter cohort study

enthalten in: World journal of clinical oncology | 2022

von Falco, A. | Leiva, M. | Blanco, A. | +10

3

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Powles, T. | Csőszi, T. | Özgüroğlu, M. | +118

CommentIn: Lancet Oncol. 2021 Jul;22(7):894-896. - PMID 34051179

4

Platinum ineligibility in squamous cell carcinoma of the head and neck : consensus from Central America and the Caribbean

enthalten in: Future oncology (London, England) | 2021

von Alvarado-Muñoz, J. | Falco, A. | Morales, A. | +8

5

Defining the needs of patients with recurrent and/or metastatic head and neck cancer : An expert opinion

enthalten in: Critical reviews in oncology/hematology | 2021

von Oliveira, T. | Mesía, R. | Falco, A. | +7

6

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin : Recommendations for Clinical Practice

enthalten in: Cancer management and research | 2021

von Falco, A. | de Oliveira, T. | Cacicedo, J. | +12

1
[1]